Searched for
NV PRASAD
Kotak Alt invests Rs 1445 crore for the acquisition of Viatris' API business by Matrix PharmaKotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient (A...- Edelweiss fund to back Matrix Lab founder's buyout of Viatris API bizKotak is lending $150 million (₹1,250 crore) under a mezzanine debt facility to Prasad at 18-20% and arranging an additional $300 million f...
- Kotak Fund to part finance matrix lab founder's Viatris buyThe fund plans to provide a $150 million mezzanine debt facility at 18-20% and arrange another $300 million from other lenders to finance t...
- Matrix Laboratories founder buys back API Biz from ViatrisNimmagadda Prasad, the founder of Matrix Laboratories, has bought back the active pharmaceutical ingredients (API) business he sold to Myla...
- Matrix Labs founder buys back Viatris' API business in IndiaViatris' latest transaction includes three manufacturing sites and a R&D lab in Hyderabad, three manufacturing sites in Vizag and third-par...
- Supreme Court asks UP govt to give FIR, arrest details on Lakhimpur Kheri case todayThe state has ordered a judicial enquiry into the incident and two people were questioned on Thursday, four days after the incident.
- Recommend successor, Centre writes to Chief Justice S A BobdeLaw minister Ravi Shankar Prasad wrote to CJI Bobde requesting him to nominate his successor, who would be appointed as the 48th CJI, offic...
- Granules India to divest entire stake in Granules OmniChem to JV partnerSA Ajinomoto Omnichem NV will take over full control of the contract research and manufacturing services (CRAMS) business, said Granules In...
- You may Soon Get Real-time Data on BMTC ScheduleBMTC has come up with a draft policy on open data, the first step towards enabling private individuals to access real-time bus information.
- Under financial stress, BMTC puts out ad for Rs 160 crore loanIt wants funds to settle PF, insurance premium and gratuity of employees.
- BMTC plans to overhaul Bengaluru bus service by 2030“We are looking at a long-term plan on increasing fleet size, increasing operational efficiency and reducing losses,” BMTC managing directo...
- BMTC allowed to buy 1,000 buses, but it’s unable to...Petition in National Green Tribunal wants transport corporation to buy only CNG buses.
- Real estate assets in Karnataka to get expensive from AprilGuidance value is an indicative market value of a property, and the government would register a sale transaction only at that given value o...
- No uniform rule possible on sting operations: Supreme CourtThe Supreme Court on Thursday said no uniform rule can be laid down on the legality of sting operations as that would leave scope for abuse...
- Indian Air Force signs MoU with JNTUJNTU signed an MoU for the 'Flight Navigator Programme' at Navigation Training School at the Air Force Station in Begumpet here.
- NYSE Euronext approves delisting of Octoplus shares: Dr Reddy's LaboratoriesDr Reddy's Laboratories has said delisting of the subsidiary's shares in Euronext has been approved by NYSE Euronext Amsterdam.
- Dr Reddy's Laboratories acquires 93% shares of OctoPlusDr Reddy's Laboratories has so far managed to get nearly 93% shares of Netherlands-based speciality pharmaceutical company OctoPlus NV.
- Dr Reddy's acquires 80% shares in OctoPlusThe transaction is expected to be completed by the end of the current financial year, G V Prasad, vice chairman and chief executive officer...
- Dr Reddy's public offer for Octoplus begins todayOn October 22, the Indian drug major had announced that it had decided to acquire OctoPlus NV for about 27.4 million euro (about Rs 193 cro...
- Dr Reddy's Laboratories to acquire OctoPlus NV for 27.39 million eurosDr Reddy’s Labs has agreed to buy the entire equity holding of OctoPlus NV for 27.39 million euros (Rs 191.72 crore) in an all cash deal.
Load More
